Medical Aesthetics M&A
M&A guidance for medical spas, aesthetic practices, cosmetic dermatology businesses and multi site platforms pursuing growth, partnership or liquidity.
A consumer healthcare growth sector
Medical aesthetics combines healthcare regulation, consumer brand dynamics and recurring service relationships, creating opportunities and risks that differ from a traditional medical practice or consumer business.
Buyers may value a platform for provider productivity, patient retention, location economics, brand strength and the potential to add services or sites. They also scrutinize physician supervision, scope of practice, fee splitting, device ownership, marketing compliance and the durability of patient relationships.
Northeastern Advisors helps acquirers and owners connect strategy with transaction execution. We assess the operating model, financial quality and growth plan that support value, then manage outreach, negotiation and diligence through closing.
Advisory services
We help strategic platforms, private equity firms and family offices identify practices that fit their clinical, geographic and growth strategy.
We help owners assess partnership and sale alternatives, prepare for buyer review and position the business around its strongest transferable qualities.
Sector knowledge
The best businesses combine responsible clinical oversight with repeat patient demand, productive providers and reliable location economics.
Buyers need to understand which earnings are transferable, how the provider model works and whether growth can continue without depending on one physician, injector or marketing channel.
Revenue, retention and utilization by physician, injector and aesthetician, together with compensation economics.
Repeat treatment patterns, membership revenue, visit frequency, cross selling and patient concentration.
The balance of injectables, devices, skin services, memberships and other offerings, including margin by category.
Medical supervision, scope of practice, protocols, charting and compliance with state ownership and fee rules.
Maturity, contribution margin, capacity and the investment required to open or integrate additional sites.
Reputation, reviews, referral sources, digital marketing efficiency and dependence on paid lead generation.
A disciplined transaction process
Define growth, liquidity, rollover equity, clinical role and timing preferences.
Review normalized earnings, providers, patients, services, sites, compliance and growth capacity.
Build the buyer, investor or target universe most relevant to the strategy.
Present the clinical model, brand, performance and expansion plan with credible support.
Compare economics and nonfinancial terms, then coordinate financial, legal and clinical review.
Align employment, governance, integration and patient continuity before closing.
Research and market intelligence
A practical overview of the financial and operating factors that influence healthcare practice value.
Explore resource →Key preparation issues for regulated healthcare companies entering a transaction process.
Explore resource →Common financial, compliance and operating problems that can reduce value or stop a transaction.
Explore resource →Understand likely value, improve readiness and choose among sale, partnership and growth alternatives.
Explore resource →Build an acquisition thesis and evaluate practices against the strategy, not just a headline multiple.
Explore resource →Prepare for financial, legal and operating verification before signing a definitive agreement.
Explore resource →Frequently asked questions
Buyers may include private equity backed platforms, strategic operators, physician groups, family offices and entrepreneurs. The relevant universe depends on geography, ownership rules, provider model and scale.
Buyers often examine revenue by service and provider, patient retention, membership activity, provider tenure, marketing cost, device utilization, location contribution and the percentage of revenue tied to a key clinician.
Corporate practice of medicine, fee splitting, medical director and scope of practice rules vary by state. Transactions may use management services structures or other arrangements designed by qualified healthcare counsel.
Often, yes. Some buyers offer rollover equity or partnership structures, but the economics, governance, liquidity path and risks should be evaluated alongside the cash paid at closing.
Reliable monthly reporting, clear provider agreements, documented clinical oversight, patient and service metrics, clean add backs and reduced dependence on one practitioner can materially improve buyer confidence.
A confidential conversation
Whether you are considering a platform acquisition, adding locations, seeking a capital partner or preparing for a sale, we can help frame the opportunity and manage the transaction.
Schedule a Consultation →